J Finsterer

Summary

Country: Germany

Publications

  1. ncbi Severe hypokalemic paralysis as a manifestation of a mitochondrial disorder
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Tohoku J Exp Med 231:9-12. 2013
  2. ncbi Neurological complications of cardiac disease (heart brain disorders)
    Josef Finsterer
    Rudolfstiftung Hospital, Vienna, Austria
    Minerva Med 107:14-25. 2016
  3. doi The Eye on Mitochondrial Disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    J Child Neurol 31:652-62. 2016
  4. doi Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180, Vienna, Austria
    J Mol Neurosci 58:321-9. 2016
  5. doi Syncope and hyperCKemia as minimal manifestations of short CTG repeat expansions in myotonic dystrophy type 1
    Josef Finsterer
    Kar Vienna, Vienna, Austria Electronic address
    Rev Port Cardiol 34:361.e1-4. 2015
  6. doi Fasciculations in human hereditary disease
    Josef Finsterer
    Krankenanstalt Rudolfstiftung Vienna, Postfach 20, 1180, Vienna, Austria
    Acta Neurol Belg 115:91-5. 2015
  7. doi Seizure-triggered Takotsubo syndrome rarely causes SUDEP
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria Electronic address
    Seizure 31:84-7. 2015
  8. ncbi Adult, isolated respiratory chain complex IV deficiency with minimal manifestations
    Josef Finsterer
    Josef Finsterer, MD, PhD, Postfach 20, 1180 Vienna, Austria, phone 43 1 71165 92085, fax 43 1 4781711, E mail
    Folia Neuropathol 53:153-7. 2015
  9. doi Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    J Neurol Sci 355:37-43. 2015
  10. doi Abnormalities of Skin and Cutaneous Appendages in Neuromuscular Disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Pediatr Neurol 53:301-8. 2015

Detail Information

Publications193 found, 100 shown here

  1. ncbi Severe hypokalemic paralysis as a manifestation of a mitochondrial disorder
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Tohoku J Exp Med 231:9-12. 2013
    ..Endocrine involvement may be a phenotypic feature of MtD. ..
  2. ncbi Neurological complications of cardiac disease (heart brain disorders)
    Josef Finsterer
    Rudolfstiftung Hospital, Vienna, Austria
    Minerva Med 107:14-25. 2016
    ..Heart disease is a frequent cause of cerebral compromise. This review aimed at summarising and discussing available data about heart brain disorders...
  3. doi The Eye on Mitochondrial Disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    J Child Neurol 31:652-62. 2016
    ..Ophthalmologic manifestations of mitochondrial disorders need to be appropriately diagnosed to initiate the most effective management and guarantee optimal outcome. ..
  4. doi Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180, Vienna, Austria
    J Mol Neurosci 58:321-9. 2016
    ..Since life expectancy is hardly reduced in SBMA, re-investigation of patients from published studies with regard to their initial disease profiles is recommended. ..
  5. doi Syncope and hyperCKemia as minimal manifestations of short CTG repeat expansions in myotonic dystrophy type 1
    Josef Finsterer
    Kar Vienna, Vienna, Austria Electronic address
    Rev Port Cardiol 34:361.e1-4. 2015
    ..Syncope and palpitations as the only initial manifestations of myotonic dystrophy type 1 (MD1) due to a CTG expansion of 50-100 repeats have not been reported...
  6. doi Fasciculations in human hereditary disease
    Josef Finsterer
    Krankenanstalt Rudolfstiftung Vienna, Postfach 20, 1180, Vienna, Austria
    Acta Neurol Belg 115:91-5. 2015
    ....
  7. doi Seizure-triggered Takotsubo syndrome rarely causes SUDEP
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria Electronic address
    Seizure 31:84-7. 2015
    ..Fatalities are rare in patients experiencing seizure-triggered TTS. This is why seizure-triggered TTS does not seem to play a major role in the pathogenesis of SUDEP...
  8. ncbi Adult, isolated respiratory chain complex IV deficiency with minimal manifestations
    Josef Finsterer
    Josef Finsterer, MD, PhD, Postfach 20, 1180 Vienna, Austria, phone 43 1 71165 92085, fax 43 1 4781711, E mail
    Folia Neuropathol 53:153-7. 2015
    ..Here we report an adult with isolated complex IV deficiency with unusually mild clinical manifestations...
  9. doi Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    J Neurol Sci 355:37-43. 2015
    ..Anterocollis as a rare subtype of cervical dystonia is difficult to treat and thus less appreciated than other subtypes of cervical dystonia. This review aimed at summarising and discussing recent advances in the management of anterocollis...
  10. doi Abnormalities of Skin and Cutaneous Appendages in Neuromuscular Disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Pediatr Neurol 53:301-8. 2015
    ..However, the skin is more frequently affected in neuromuscular disorders and deserves more attention than so far acknowledged...
  11. doi Sudden cardiac death in neuromuscular disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Int J Cardiol 203:508-15. 2016
    ..Some of these patients even experience sudden cardiac death (SCD). In the following review, we summarize recent findings concerning epidemiology, risk stratification, and prevention of SCD in NMDs...
  12. doi Review of Cardiac Disease in Nemaline Myopathy
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Pediatr Neurol 53:473-7. 2015
    ..This review summarizes and discusses findings concerning the type, prevalence, diagnosis, treatment, and outcome of cardiac involvement in nemaline myopathy...
  13. doi Therapeutic strategies for mitochondrial disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Pediatr Neurol 52:302-13. 2015
    ..This review highlights potential strategies for the therapeutic management of mitochondrial disorders...
  14. doi Fatigue in healthy and diseased individuals
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Am J Hosp Palliat Care 31:562-75. 2014
    ..Although fatigue is experienced by everyone, its definition and classification remains under debate...
  15. doi Mitochondrial toxicity of cardiac drugs and its relevance to mitochondrial disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria, Europe 43 1 71165 92085 43 1 4781711
    Expert Opin Drug Metab Toxicol 11:15-24. 2015
    ..This review focuses on the mitochondrion-toxic effects of cardiac drugs and the extent to which mitochondrion-mediated side effects influence the treatment of cardiac disease in mitochondrial disorders (MIDs)...
  16. doi CNS disease triggering Takotsubo stress cardiomyopathy
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Int J Cardiol 177:322-9. 2014
    ..TTS is one of the cardiac abnormalities most frequently induced by CNS disorders. Appropriate management of TTS from CNS disorders is essential to improve the outcome of affected patients. ..
  17. doi Cardiac manifestations of primary mitochondrial disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Int J Cardiol 177:754-63. 2014
    ..Cardiac involvement (CI) in MIDs has therapeutic and prognostic implications. This review aims at summarizing and discussing the various cardiac manifestations in MIDs...
  18. doi Parasitoses with central nervous system involvement
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Juchgasse 25, 1030, Vienna, Austria
    Wien Med Wochenschr 164:400-4. 2014
    ..Treatment is based on various antihelminthic agents and, occasionally, surgery. ..
  19. doi Haematological features in Barth syndrome
    Josef Finsterer
    Neurological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Curr Opin Hematol 20:36-40. 2013
    ..This review highlights recent advances concerning pathogenesis, clinical presentation, diagnosis and treatment of Barth syndrome with particular regard to haematological abnormalities (e.g., neutropenia)...
  20. doi Distal myosin heavy chain-7 myopathy due to the novel transition c.5566G>A (p.E1856K) with high interfamilial cardiac variability and putative anticipation
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Neuromuscul Disord 24:721-5. 2014
    ..Cardiac involvement may be present in MYH7-myopathy and may be progressive between the generations, ranging from relaxation abnormality to noncompaction, ventricular arrhythmias, and dilated cardiomyopathy...
  21. doi Recent progress in the genetics of motor neuron disease
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria Electronic address
    Eur J Med Genet 57:103-12. 2014
    ..Genetic background and pathogenesis of motor neuron diseases (MNDs) have been increasingly elucidated over recent years...
  22. pmc Cerebellar nocardiosis and myopathy from long-term corticosteroids for idiopathic thrombocytopenia
    Marlies Frank
    First Medical Department, Hospital Rudolfstiftung, Vienna, Austria
    Yonsei Med J 51:131-7. 2010
    ..Cerebral nocardiosis may not sufficiently respond to long-term antibiotic therapy why switching to alternative antibiotics or surgery may be necessary...
  23. pmc Seizure as initial manifestation of aortic dissection type a
    Josef Finsterer
    Vienna, Austria, Europe
    West J Emerg Med 11:510-1. 2010
    ..Seizure as the initial manifestation of aortic dissection is rare...
  24. pmc Apply Awaji-shima Consensus Conference Criteria Before Diagnosing Amyotrophic Lateral Sclerosis
    Josef Finsterer
    Danube University Krems, Krems, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Open Neurol J 7:4-6. 2013
    ..ALS may be diagnosed although affection of other organs suggests another pathogenetic back-ground...
  25. pmc Stroke and Stroke-like Episodes in Muscle Disease
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Danube University Krems, Austria
    Open Neurol J 6:26-36. 2012
    ..This review aims to summarize and discuss current knowledge about stroke in myopathies and to delineate stroke-like episodes from ischemic stroke...
  26. pmc Lift the quilt in case of atrial fibrillation and disc prolapse
    Adam Bastovansky
    Department of Radiology, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Vasc Health Risk Manag 8:389-92. 2012
    ..Peripheral embolism to the lower extremities may mimic disc prolapse with severe consequences...
  27. pmc Favorable Outcome of Ramsay Hunt Syndrome under Dexamethasone
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria
    Case Report Med 2012:247598. 2012
    ..Ramsay Hunt syndrome was diagnosed. Instead of prednisolone she received dexamethasone (40 mg/d) but nonetheless recovered completely after 12 weeks...
  28. pmc Novel m.15434C>A (p.230L>I) Mitochondrial Cytb Gene Missense Mutation Associated with Dilated Cardiomyopathy
    Sinda Zarrouk Mahjoub
    Genetics Laboratory and Research Unit of Genetics Epidemiology and Molecular, Faculty of Medicine of Tunis, Tunis 1007, Tunisia
    ISRN Cardiol 2012:251723. 2012
    ..Conclusions. Though the L230I mutation seems to play a causative role for dCMP, prospective studies on yeast or transgenic mice models with defined mutation are warranted to study the pathogenetic impact of this mutation...
  29. pmc Catheter ablation of multiple accessory pathways in duchenne muscular dystrophy
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Korean Circ J 43:115-8. 2013
    ..This case shows that cardiac involvement in DMD may manifest also as WPW-syndrome. In these patients, repeated radio-frequency catheter ablation of accessory pathways may be necessary to completely block the re-entry mechanism...
  30. doi Unclassified cardiomyopathies in neuromuscular disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180, Vienna, Austria
    Wien Med Wochenschr 163:505-13. 2013
    ..Unclassified CMPs are frequently associated with noncardiac disease, including neuromuscular disorders (NMDs). This review aims at summarizing and discussing recent findings concerning the association of NMDs with unclassified CMPs...
  31. ncbi Repurposed drugs in metabolic disorders
    Josef Finsterer
    Postfach 20, 1180 Vienna, Austria
    Curr Top Med Chem 13:2386-94. 2013
    ..Future investigations will need to identify which candidate drugs may leave the pipeline status to acquire approval for new indications. ..
  32. doi Mitochondrial epilepsy in pediatric and adult patients
    J Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Acta Neurol Scand 128:141-52. 2013
    ..To optimize management of mitochondrial epilepsy, it is essential to differentiate between early and late-onset forms. ..
  33. doi Dementia from the ABCD1 mutation c.1415-1416delAG in a female carrier
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Gene 530:155-7. 2013
    ..We report a unique female X-ALD carrier presenting with severe, progressive dementia, paraspasticity, sphincteric dysfunction, and multisystem disease...
  34. doi Influence of mitochondrion-toxic agents on the cardiovascular system
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Regul Toxicol Pharmacol 67:434-45. 2013
    ..Particularly coenzyme-Q, riboflavin, vitamin-E, vitamin-C, L-carnitine, vitamin-D, thiamin, folic acid, omega-3 fatty acids, and D-ribose may alleviate mitochondrial cardiotoxic effects...
  35. doi Hirayama disease in Austria
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria Electronic address
    Joint Bone Spine 80:503-7. 2013
    ..The study aimed at systematically collecting cases of HD in Austria and at describing and discussing their presentation on clinical and instrumental investigations and at comparing them with cases reported from other countries...
  36. doi Parasitoses of the human central nervous system
    J Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    J Helminthol 87:257-70. 2013
    ..g. Angiostrongylus costaricensis) or whether they remain undetected or asymptomatic, like 25% of neurocysticerciasis cases. ..
  37. doi Cardiomyopathy in neurological disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria Electronic address
    Cardiovasc Pathol 22:389-400. 2013
    ..Which patients with cardiomyopathy profit most from primary stroke prevention is unsolved and requires further investigations. ..
  38. doi Sudden death possibly related to lenalidomide given for cardiac and muscle AL amyloidosis secondary to light chain deposition disease
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    J Oncol Pharm Pract 19:170-4. 2013
    ..Restrictive cardiomyopathy due to AL amyloidosis has not been reported as the cause of sudden death. The risk of sudden death in AL amyloidosis may be further increased by potentially cardiotoxic medication, as in the following case...
  39. ncbi Brachydactylia as a phenotypic feature of mitochondrial disorder
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Acta Med Iran 50:831-5. 2012
    ..The family history was positive for diabetes but negative for brachydactylia or other features of a MID. MIDs may be associated with brachydactylia. Skeletal deformities may be a phenotypic manifestation of MIDs...
  40. doi Familal left ventricular hypertrabeculation (noncompaction) is myopathic
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Danube University Krems, Austria
    Int J Cardiol 164:312-7. 2013
    ..In most cases LVHT is associated with neuromuscular disorders (NMDs) or other rare non-neuromuscular genetic syndromes. Occasionally, LVHT occurs familiarly...
  41. ncbi Alive with almost no Brain: Severe Post-Hemorrhagic Internal Hydrocephalus
    J Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, Vienna, Vienna 1180, Austria
    Med J Malaysia 68:86-7. 2013
    ..Severe post-hemorrhaghic internal hydrocephalus with almost complete atrophy of the cerebral parenchyma, as in the following case, is rare...
  42. doi Presentation of adult mitochondrial epilepsy
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Seizure 22:119-23. 2013
    ..We were interested in the types of epilepsy, the prevalence of mitochondrial epilepsy, the type and effectiveness of treatment, and in the outcome of adult MID patients with epilepsy...
  43. doi Thrombolysis of ischemic stroke from noncompaction in metabolic myopathy
    Josef Finsterer
    Neurological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Neurologist 18:296-7. 2012
    ..Ischemic stroke has not been reported together with left ventricular hypertrabeculation/noncompaction (LVHT) and metabolic myopathy...
  44. ncbi Beneficial effect of ivabradine in dilated cardiomyopathy from Becker muscular dystrophy
    J Finsterer
    Danube University Krems, Krems, Osterreich
    Herz 37:702-5. 2012
    ..The I(f) blocker ivabradine reduces heart rate and improves systolic function without causing arterial hypotension. Ivabradine has not been reported to improve cardiac involvement in Becker muscular dystrophy (BMD)...
  45. doi Leukoencephalopathies in mitochondrial disorders: clinical and MRI findings
    Josef Finsterer
    Danube University Krems, Krems, Austria
    J Neuroimaging 22:e1-11. 2012
    ..Because the presence of LEM has an impact on the prognosis of an MID, all MID patients should undergo cerebral imaging even in the absence of clinical CNS manifestations...
  46. doi Arrhythmia-related workup in hereditary myopathies
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    J Electrocardiol 45:376-84. 2012
    ..Arrhythmias determine life expectancy in patients with hereditary myopathies...
  47. doi Cognitive dysfunction in mitochondrial disorders
    J Finsterer
    Danube University Krems, Krems and Krankenanstalt Rudolfstiftung, Vienna, Austria
    Acta Neurol Scand 126:1-11. 2012
    ..Cognitive impairment may be a CNS manifestation of syndromic as well as non-syndromic MIDs. Correct diagnosis of mitochondrial cognitive impairment is a prerequisite for the optimal management of these patients...
  48. doi Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Wien, Austria
    J Neurol Sci 318:1-18. 2012
    ..Among the XL-SPGs, 3 causative genes have been identified (L1CAM (SPG1), PLP1 (SPG2), and SLC16A2 (SPG22)). The diagnosis of SPGs is based on clinical, instrumental and genetic investigations. Treatment is exclusively symptomatic...
  49. doi Epilepsy in mitochondrial disorders
    Josef Finsterer
    Danube University Krems, Krems, Austria
    Seizure 21:316-21. 2012
    ..Aim of the review was to describe epilepsy in syndromic and non-syndromic mitochondrial disorders with epilepsy as a dominant or collateral feature of the phenotype...
  50. doi Mimicry between mitochondrial disorder and multiple sclerosis
    Josef Finsterer
    Danube University Krems, Austria
    Metab Brain Dis 27:217-20. 2012
    ..It is concluded that even if CSF investigations or imaging studies suggest MS, differentials such as MIDs need to be excluded before prescribing medication possibly toxic to a MID. An "inflammatory CSF" may also occur in MIDs...
  51. doi Dilative arteriopathy in metabolic myopathies, particularly Pompe's disease
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria
    Acta Neurol Belg 112:15-8. 2012
    ..Early recognition of ectasias and aneurysms and appropriate interventions by enzyme replacement therapy, stenting, coiling or surgery may prevent mild or severe cerebrovascular complications or even death in some of these patients...
  52. doi Inherited mitochondrial disorders
    Josef Finsterer
    Danube University Krems, Vienna, Austria Europe
    Adv Exp Med Biol 942:187-213. 2012
    ..Genetic testing should be guided by the phenotype, the biopsy findings, and the biochemical results...
  53. ncbi Dopamine-deficiency-enhanced hyperthermia and rhabdomyolysis during a heat wave in a metachromatic leucodystrophy heterozygote with metabolic myopathy
    Josef Finsterer
    Acta Neurol Belg 111:321-4. 2011
    ..Hyper-CK-emia returned to similar levels as before rhabdomyolysis. Reduction of dopamine agonists during a heat wave may induce a dopamine deficiency syndrome with hyperthermia, rhabdomyolysis and thrombocytopenia...
  54. ncbi Neuromuscular disorders in left ventricular hypertrabeculation/noncompaction
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Curr Pharm Des 16:2895-904. 2010
    ....
  55. ncbi EFNS guidelines on the molecular diagnosis of mitochondrial disorders
    J Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Danube University Krems, Krems, Austria
    Eur J Neurol 16:1255-64. 2009
    ....
  56. doi [Diagnosis of myopathies]
    J Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Fortschr Neurol Psychiatr 78:382-93. 2010
    ..For diagnostic, therapeutic and prognostic implications, diagnostic work-up should be carried out as soon as possible if myopathy is suspected...
  57. ncbi Mitochondrial disorder mimicking ocular myasthenia
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria, Europe
    Acta Neurol Belg 110:110-2. 2010
    ..Ocular myasthenia (OM) and mitochondrial disorder (MID) may be easily mixed up, if the MID presents with similar manifestations as OM and if MID manifestations progress only slowly...
  58. doi Cardiac and cerebral air embolism from endoscopic retrograde cholangio-pancreatography
    Josef Finsterer
    Second Medical Department, Institute of Radiology, Krankenanstalt Rudolfstiftung, Vienna, Austria, Europe
    Eur J Gastroenterol Hepatol 22:1157-62. 2010
    ....
  59. doi Left ventricular non-compaction and its cardiac and neurologic implications
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Danube University Krems, Krems, Postfach 20, 1180, Vienna, Austria
    Heart Fail Rev 15:589-603. 2010
    ..Though initially assessed as poor, the prognosis of LVHT has meanwhile improved, most likely due to the increased awareness for the abnormality and the timely administration of adequate therapy...
  60. doi Stroke in myopathies
    Josef Finsterer
    Neurological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Cerebrovasc Dis 29:6-13. 2010
    ..Only few data are available about the risk of myopathy patients experiencing a cerebral stroke...
  61. doi [Mitochondrial myopathies]
    J Finsterer
    Krankenanstalt Rudolfstiftung, Wien Osterreich
    Fortschr Neurol Psychiatr 77:631-8. 2009
    ..General anesthesia needs to be performed in the same way as in patients with susceptibility for malignant hyperthermia...
  62. doi Drugs interfering with mitochondrial disorders
    Josef Finsterer
    Neurological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Drug Chem Toxicol 33:138-51. 2010
    ..This review aims to give an overview about those agents that interfere with mitochondrial functions...
  63. doi Management of mitochondrial stroke-like-episodes
    J Finsterer
    Krankenanstalt Rudolfstiftung, Vienna and Danube University, Krems, Austria
    Eur J Neurol 16:1178-84. 2009
    ..The most effective strategy for the treatment of SLEs appears to be the application of L-arginine, coenzyme-Q, steroids, edaravone, creatine-monohydrate, or dichloracetate...
  64. doi Disappearance of episodic weakness during pregnancy in hyperkalemic periodic paralysis from the SCNA4 mutation T704M
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria, Europe
    Neurologist 15:289-90. 2009
    ..Disappearance of episodic weakness during pregnancy and an increase in myotonia after delivery have not been reported in hyperkalemic periodic paralysis (hyperPP)...
  65. doi Malignant hyperthermia susceptibility in a patient with mitochondrial disorder
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria
    Metab Brain Dis 24:501-6. 2009
    ..Though previous general anesthesias had been carried out without major complications, it cannot be ruled out that MH-like manifestations may develop during future anesthesias if trigger agents are not avoided...
  66. doi Treatment of mitochondrial disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Eur J Paediatr Neurol 14:29-44. 2010
    ..Despite limited possibilities, symptomatic treatment should be offered to MID patients, since it can have a significant impact on the course and outcome...
  67. doi [Neurological complications of atrioesophageal fistulas: postprandial insults, epilepsy and meningitis]
    J Finsterer
    Krankenanstalt Rudolfstiftung, Wien, Osterreich
    Nervenarzt 82:198-201. 2011
    ..AEFs result in an overflow of esophageal contents into the left atrium with subsequent systemic embolization...
  68. doi Presentation, etiology, diagnosis, and management of camptocormia
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Eur Neurol 64:1-8. 2010
    ..The outcome is generally fair. Some patients profit from therapy whereas others do not respond to treatment and become progressively immobile...
  69. doi Neurotoxocariasis associated with lower motor neuron disease. Report of one case
    Josef Finsterer
    Neurological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Rev Med Chil 138:483-6. 2010
    ..Whether lower motor neuron disease was causally related to neurotoxocariasis or due to a general metabolic defect, remains speculative...
  70. ncbi Brachydactylia associated with mitochondrial disorder in an octogenarian
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria
    Kobe J Med Sci 56:E239-41. 2011
    ..Whether the relation between brachydactylia and mitochondrial disease was causal or coincidental remains speculative...
  71. doi Motor neuron, nerve, and neuromuscular junction disease
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Curr Opin Neurol 24:469-74. 2011
    ..The aim is to review the most relevant findings published during the last year concerning clinical, genetic, pathogenic, and therapeutic advances in motor neuron disease, neuropathies, and neuromuscular junction disorders...
  72. doi Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    J Neurol Sci 308:139-41. 2011
    ..Usually, the course of paraneoplastic cerebellar degeneration(PCD) is stable or progresses only slowly. Sudden marked progression after several years, as in the following case, has not been reported...
  73. doi Restrictive cardiomyopathy as a cardiac manifestation of myofibrillar myopathy
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Heart Lung 40:e123-7. 2011
    ..Restrictive cardiomyopathy (RCM) has been repeatedly reported as a cardiac manifestation of certain neuromuscular disorders, but only in single patients with myofibrillar myopathy (MFMP)...
  74. ncbi Is resection of a thymoma WHO A indicated in the absence of myasthenia gravis?
    J Finsterer
    Krankenanstalt Rudolfstiftung, Medical University, Vienna, Austria
    Clin Ter 162:37-9. 2011
    ..In conclusion a thymoma WHO A requires complete surgical resection, irrespective if the thymoma is accompanied by MG or not...
  75. doi Neurological manifestations of atrio-esophageal fistulas from left atrial ablation
    J Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Eur J Neurol 18:1212-9. 2011
    ..Diagnostic work-up must avoid measures, which enlarge the fistula. Treatment is surgical exclusively...
  76. doi Inherited mitochondrial neuropathies
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    J Neurol Sci 304:9-16. 2011
    ..Involvement of other organs may require specific treatment. Mitochondrial neuropathies should be included in the differential diagnosis of hereditary neuropathies...
  77. doi Parkinson's syndrome and Parkinson's disease in mitochondrial disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Danube University, Krems, Austria
    Mov Disord 26:784-91. 2011
    ....
  78. doi Recovery of systolic dysfunction in duchenne muscular dystrophy due to the point mutation c.4213C>T
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Cardiology 117:265-7. 2010
    ....
  79. doi Causes of camptocormia
    Josef Finsterer
    Department of Neurology, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Disabil Rehabil 33:1702-3. 2011
    ..To identify and highlight the variable causes of camptocormia...
  80. pmc Myotoxicity of telbivudine in pre-existing muscle damage
    Josef Finsterer
    Department of Neurology, Krankenanstalt Rudolfstiftung, Vienna, Austria
    Virol J 7:323. 2010
    ..It is unknown if telbivudine causes muscle damage only in patients with pre-existing muscle pathology...
  81. doi Regression of stroke-like lesions in MELAS-syndrome after seizure control
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Institute of Radiology Urania, Vienna, Austria
    Epileptic Disord 12:330-4. 2010
    ..This case indicates that adequate seizure control in a patient with MELAS syndrome may prevent the recurrence of stroke-like episodes and may result in the disappearance of stroke-like lesions on MRI...
  82. ncbi Management of cryptogenic stroke
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Acta Neurol Belg 110:135-47. 2010
    ..If the cause of CS can be identified, appropriate treatment is indicated. A PFO requires antiplatelet medication, OAC if there are other indications for OAC, and closure in case of recurrent CS under OAC...
  83. doi Perspectives of Kennedy's disease
    J Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    J Neurol Sci 298:1-10. 2010
    ..The course is slowly progressive and the ability to walk lost only late in life. Only few patients require ventilatory support and life expectancy is only slightly compromised...
  84. doi Cardiac findings in congenital muscular dystrophies
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Danube University, Krems, Vienna, Austria
    Pediatrics 126:538-45. 2010
    ..Patients with CMD with CI require regular cardiologic surveillance so that severe, treatable cardiac disease is not overlooked...
  85. doi Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders
    Josef Finsterer
    Danube University Krems, Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Krems Austria, Europe
    Expert Opin Drug Metab Toxicol 8:71-9. 2012
    ..The problem with this approach is that some antiepileptic drugs (AEDs) are mitochondrial toxic and care is, therefore, needed when administering these AEDs to patients with MIDs...
  86. doi Laminar cortical necrosis in mitochondrial disorders
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Clin Neurol Neurosurg 111:655-8. 2009
    ....
  87. doi Non-manifesting Refsum heterozygotes carrying the c.135-2A>G PAHX gene transition
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Neurol Sci 29:173-5. 2008
    ..In the absence of elevated phytanic acid concentrations, clinical neurologic abnormalities in heterozygous relatives of Refsum patients are not attributable to heterozygosity for PAHX mutations...
  88. doi Asymptomatic, nonsustained ventricular tachycardia in myotonic dystrophy type 1 detected with a loop recorder
    Josef Finsterer
    Krankenanstalt Rudolfstiftung, Vienna, Austria
    Eur Neurol 60:109-11. 2008
  89. pmc Management of peripheral facial nerve palsy
    Josef Finsterer
    Neurological Department, Krankenanstalt Rudolfstiftung, Postfach 20, 1180, Vienna, Austria
    Eur Arch Otorhinolaryngol 265:743-52. 2008
    ..Prognosis of Bell's palsy is fair with complete recovery in about 80% of the cases, 15% experience some kind of permanent nerve damage and 5% remain with severe sequelae...
  90. doi Prevalence of Barth syndrome in adult left ventricular hypertrabeculation / noncompaction
    Josef Finsterer
    Hospital Rudolfstiftung, Vienna, Austria
    Scand Cardiovasc J 42:157-60. 2008
    ..Aim of the present investigation was to determine the prevalence of these characteristics in a large cohort of adult LVHT patients...